Silence Therapeutics Plc

(OTC) SLNCF

Current Price$2.36

Market Cap$334.42M

Since IPO (2007)+79%

5 Year-69%

1 Year+148%

1 Month+18%

Silence Therapeutics Plc Financials at a Glance

Market Cap

$334.42M

Revenue (TTM)

$559.00K

Net Income (TTM)

$88.61M

EPS (TTM)

$-0.63

P/E Ratio

-3.77

Dividend

$0.00

Beta (Volatility)

-0.17 (Low)

Dividend

$0.00

Beta (Volatility)

-0.17 (Low)

Price

$2.36

Volume

1,300

Open

$2.36

Price

$2.36

Volume

1,300

Open

$2.36

Previous Close

$2.36

Daily Range

$2.36 - $2.36

52-Week Range

$0.97 - $2.60

Dividend

$0.00

Beta (Volatility)

-0.17 (Low)

Price

$2.36

Volume

1,300

Open

$2.36

Previous Close

$2.36

Daily Range

$2.36 - $2.36

52-Week Range

$0.97 - $2.60

SLNCF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Silence Therapeutics Plc

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Iain Gladstone Ross

Website

www.silence-therapeutics.com

Headquarters

London, W14 8TH, GB

SLNCF Financials

Key Financial Metrics (TTM)

Gross Margin

62%

Operating Margin

-163%

Net Income Margin

-159%

Return on Equity

Return on Capital

-77%

Return on Assets

-67%

Earnings Yield

-26.53%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$334.42M

Shares Outstanding

141.70M

Volume

1.30K

Avg. Volume

112.222

Financials (TTM)

Gross Profit

$55.00K

Operating Income

$82.29M

EBITDA

$81.73M

Operating Cash Flow

$62.27M

Capital Expenditure

$55.00K

Free Cash Flow

$62.33M

Cash & ST Invst.

$85.11M

Total Debt

$160.00K

Silence Therapeutics Plc Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$34.00K

-99.9%

Gross Profit

$377.00K

-101.7%

Gross Margin

-11.09%

N/A

Market Cap

$334.42M

N/A

Market Cap/Employee

$2.88M

N/A

Employees

116

N/A

Net Income

$11.77M

-183.0%

EBITDA

$12.52M

-274.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$85.27M

-42.1%

Accounts Receivable

$18.27M

-32.1%

Inventory

$0.00

N/A

Long Term Debt

$71.00K

N/A

Short Term Debt

$89.00K

-23.9%

Return on Assets

-67.42%

N/A

Return on Invested Capital

-77.30%

N/A

Free Cash Flow

$16.66M

+33.1%

Operating Cash Flow

$16.66M

+33.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SPHDFSanthera Pharmaceuticals Holding AG

SPHDFSanthera Pharmaceuticals Holding AG$23.25+0.00%

CMVLFCellectis S.A.

CMVLFCellectis S.A.$3.08-30.00%

GNFTFGenfit S.A.

GNFTFGenfit S.A.$9.47-14.30%

JWCTFJW (Cayman) Therapeutics Co. Ltd

JWCTFJW (Cayman) Therapeutics Co. Ltd$0.28+0.00%

OPORFhVIVO plc

OPORFhVIVO plc$0.09+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.58+2.71%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.86-0.02%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.30-0.08%

ONDSOndas

ONDSOndas$9.81-0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.85+0.03%

ADTADT

ADTADT$7.11-0.06%

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF$9.09+0.13%

Questions About SLNCF

What is the current price of Silence Therapeutics Plc?

Silence Therapeutics Plc is trading at $2.36 per share.

What is the 52-week range for Silence Therapeutics Plc?

Over the past 52 weeks, Silence Therapeutics Plc has traded between $0.97 and $2.60.

How much debt does Silence Therapeutics Plc have?

As of the most recent reporting period, Silence Therapeutics Plc reported total debt of $160,000.

How much cash does Silence Therapeutics Plc have on hand?

Silence Therapeutics Plc reported $11.28M in cash and cash equivalents in its most recent financial results.

What is Silence Therapeutics Plc’s dividend yield?

Silence Therapeutics Plc does not currently have a dividend yield.

Silence Therapeutics Plc

Silence Therapeutics Plc Financials at a Glance

SLNCF News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Silence Therapeutics Plc

SLNCF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Silence Therapeutics Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SLNCF

What is the current price of Silence Therapeutics Plc?

What is the 52-week range for Silence Therapeutics Plc?

How much debt does Silence Therapeutics Plc have?

How much cash does Silence Therapeutics Plc have on hand?

What is Silence Therapeutics Plc’s dividend yield?

Premium Investing Services